Showing results (281-290 of 295) with videos related to
Sort By:
Pageof 30
Journal of Veterinary Internal Medicine|December 7, 2018
Viral testing of 10 cases of Theiler's disease and 37 in-contact horses in the absence of equine biologic product administration: A prospective study (2014-2018)Joy E Tomlinson, Bud C Tennant, Alyssa Struzyna, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2019
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenibTim A Labeur, Sarah Berhane, Julien Edeline, et al.Hepatology Communications|December 27, 2021
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With CirrhosisHamish Innes, Hans Dieter Nischalke, Indra Neil Guha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNAAnthony T C Chan, Brigette B Y Ma, Y M Dennis Lo, et al.Animal Microbiome|December 3, 2025
A novel dataset of 2,362 equine fecal microbiomes from veterinary teaching hospitals across three countries reveals effects of geography and diseaseZachary L McAdams, Emma J Campbell, Rebecca A Dorfmeyer, et al.BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL studyPhilip J Johnson, Shukui Qin, Joong-Won Park, et al.BMC Cancer|September 18, 2023
Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-scoreThai Ngoc Truong, Trang Ngoc Doan Pham, Long Bao Hoang, et al.JCO Clinical Cancer Informatics|May 12, 2025
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival BenefitHidenori Toyoda, Atsushi Hiraoka, Hironori Ochi, et al.Gut|July 5, 2022
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control studyStephan Buch, Hamish Innes, Philipp Ludwig Lutz, et al.Pageof 30